Sarcoidosis usually presents with persistent dry cough, eye and skin manifestations, weight loss, fatigue, night sweats, and erythema nodosum. The sarcoidosis marketed and pipeline drugs assessment report provides a data-driven overview of the current and future competitive landscape in sarcoidosis therapeutics.